trial · primary record
Adjuvant, non-live RSV vaccine
Vaccine Response Impaired
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2028-03 |
| Primary endpoint | Humoral immunogenicity |
| Registry ID | NCT06593210 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:09.537Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06593210
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.